Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

45.4K
Overview
45.4K
Cancer Vaccines01:30

Cancer Vaccines

520
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
520
Preventive Healthcare Services01:30

Preventive Healthcare Services

1.1K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.1K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

2.8K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.8K
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

3.5K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.5K
Prevalence and Incidence01:08

Prevalence and Incidence

838
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
838

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI-orchestrated design-build-test-learn is the future of mammalian biodesign.

Nature biomedical engineering·2026
Same author

Finite element-guided optimization of personalized vacuum bell devices for pectus excavatum: an exploratory retrospective clinical study.

Pediatric surgery international·2026
Same author

Sodium Humate Chelating Ferrous Ions in the Aqueous Synthesis of High-Purity Sulfate Cathode Materials for Sustainable Sodium Ion Storage.

ChemSusChem·2026
Same author

Hsa_circ_0003258 drives serine biosynthesis and docetaxel resistance in prostate cancer by enhancing IGF2BP3-mediated PSAT1 mRNA stability.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2026
Same author

Patient preferences for managing chronic breast cancer-related lymphedema in China: evidence from a discrete choice experiment.

BMC health services research·2026
Same author

Progress of Plastic and Aesthetic Industry in Mainland China: A National Data Comparison between Public and Private Hospitals.

Aesthetic plastic surgery·2026

Related Experiment Video

Updated: Sep 18, 2025

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.6K

Global HPV vaccination programs and coverage rates: a systematic review.

Jingjing Han1,2,3, Li Zhang1, Yuqing Chen3

  • 1School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, China.

Eclinicalmedicine
|June 23, 2025
PubMed
Summary

Global human papillomavirus (HPV) vaccination coverage is below the 90% target, with only 47.6% receiving full doses in 2023. Enhanced strategies are needed to increase HPV immunization rates worldwide.

Keywords:
Cervical cancerHuman papillomavirusVaccination coverageVaccination program

More Related Videos

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.6K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

27.6K

Related Experiment Videos

Last Updated: Sep 18, 2025

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.6K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.6K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

27.6K

Area of Science:

  • Public Health
  • Immunology
  • Epidemiology

Background:

  • Many nations have integrated the human papillomavirus (HPV) vaccine into their national immunization schedules.
  • Comprehensive global data on HPV vaccination coverage is limited.
  • This study addresses the need for an in-depth analysis of worldwide HPV immunization programs and coverage.

Purpose of the Study:

  • To provide a comprehensive overview of current global HPV immunization programs.
  • To assess worldwide HPV vaccination coverage rates.
  • To analyze trends in HPV vaccination and cervical cancer incidence.

Main Methods:

  • Systematic search of PubMed, Embase, WHO database, and websites for HPV vaccination policies and coverage data from 194 WHO member states.
  • Analysis of population-based HPV vaccination coverage rates from 2010-2023.
  • Evaluation of cervical cancer incidence trends in 15 early-adopter countries and subgroup analyses by sex and age.

Main Results:

  • As of February 2025, 148 countries have national HPV vaccination programs.
  • In 2023, weighted average coverage for girls aged 9-14 was 61.6% for the first dose and 47.6% for the full dose.
  • Upper-middle income countries showed the highest coverage (71.7% for the first dose); cervical cancer incidence is declining in most assessed countries.

Conclusions:

  • Global HPV vaccination coverage significantly lags behind the 90% target.
  • Urgent development and implementation of strategies are required to improve HPV vaccination rates.
  • Declining cervical cancer incidence trends correlate with HPV vaccination efforts.